Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | 50,000 | reported | 02 Jan 2026 | tx 14+236,341 |
| Pharvaris N.V. | 15,167 | reported | 20 May 2026 | tx 3+10,000−20,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 May 2026 | EXERCISE | Pharvaris N.V. | 10,000 | 8.05 USD | 10b5-1 |
| 20 May 2026 | SALE | Pharvaris N.V. | 10,000 | 29.32 USD | 10b5-1 |
| 20 May 2026 | EXERCISE | Pharvaris N.V. | 10,000 | 0.00 USD | 10b5-1deriv |
| 02 Jan 2026 | PURCHASE | ROCKET PHARMACEUTICALS, INC. | 10,000 | 3.44 USD | |
| 27 Aug 2025 | PURCHASE | ROCKET PHARMACEUTICALS, INC. | 10,000 | 3.41 USD | |
| 18 Jun 2025 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 30,000 | 0.00 USD | |
| 26 Sept 2024 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 607 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 23,944 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 3,325 | 15.04 USD | deriv |
| 22 Jun 2023 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 3,590 | 13.93 USD | deriv |
| 22 Jun 2023 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 25,850 | 0.00 USD | deriv |
| 13 Jun 2022 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 7,345 | 6.80 USD | deriv |
| 13 Jun 2022 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 47,745 | 0.00 USD | deriv |
| 14 Jun 2021 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 12,236 | 0.00 USD | deriv |
| 14 Jun 2021 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 1,699 | 29.42 USD | deriv |
| 16 Jun 2020 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 20,000 | 0.00 USD | deriv |
| 20 Apr 2020 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 40,000 | 0.00 USD | deriv |